Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

about

Erythropoiesis: insights into pathophysiology and treatments in 2017.Fetal Hemoglobin Induction by Epigenetic Drugs Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain

P2860

Q55436035-B3D9D451-58ED-4A1C-858E-D7D1763EDFF9 Q57753972-C823A3F8-8EFC-49A2-8186-760914287EC0 Q58776995-19432781-CE77-453B-A1EC-8AFB50950FE8

P2860

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Item

http://www.wikidata.org/entity/Q41576877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.

@en

type

Item

label

Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.

@en

prefLabel

Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.

@en

P1476

Oral tetrahydrouridine and dec ...... se: A randomized phase 1 study

@en

P2093

Donald Lavelle

http://www.w3.org/2001/XMLSchema#string

Johara Hassan

http://www.w3.org/2001/XMLSchema#string

John F Tisdale

http://www.w3.org/2001/XMLSchema#string

Joseph DeSimone

http://www.w3.org/2001/XMLSchema#string

Lani Krauz

http://www.w3.org/2001/XMLSchema#string

Maria A Ruiz

http://www.w3.org/2001/XMLSchema#string

Michael Pacini

http://www.w3.org/2001/XMLSchema#string

Philip Woost

http://www.w3.org/2001/XMLSchema#string

Robert Molokie

http://www.w3.org/2001/XMLSchema#string

Santhosh Saraf

http://www.w3.org/2001/XMLSchema#string

P2860

CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil.

Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.

Fine tuning of globin gene expression by DNA methylation.

Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.

LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.

Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

P304

e1002382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1002382

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28880867

http://www.w3.org/2001/XMLSchema#string

P932

5589090

http://www.w3.org/2001/XMLSchema#string

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

about

P2860

P2860

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932